Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.,
Mondello, Patrizia, Tadros Saber, Teater Matt, Fontan Lorena, Chang Aaron Y., Jain Neeraj, Yang Haopeng, Singh Shailbala, Ying Hsia-Yuan, Chu Chi-Shuen, et al.
, Cancer Discov, 2020 Mar, Volume 10, Issue 3, p.440-459, (2020)
SYK inhibition and response prediction in diffuse large B-cell lymphoma.,
Cheng, Shuhua, Coffey Greg, X Zhang Hannah, Shaknovich Rita, Song Zibo, Lu Pin, Pandey Anjali, Melnick Ari M., Sinha Uma, and Y Wang Lynn
, Blood, 2011 Dec 08, Volume 118, Issue 24, p.6342-52, (2011)